La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Pennant Group Dividendo

Dividendo criteri di controllo 0/6

Pennant Group non ha registrato alcun pagamento di dividendi.

Informazioni chiave

n/a

Rendimento del dividendo

n/a

Rapporto di remunerazione

Rendimento medio del settore	1.6%
Prossima data di pagamento dei dividendi	n/a
Data di stacco del dividendo	n/a
Dividendo per azione	n/a
Utile per azione	US$0.64
Previsione del rendimento del dividendo a 3 anni	n/a

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Dec 25

Pennant Group (NASDAQ:PNTG) Is Reinvesting At Lower Rates Of Return

Sep 02

Pennant acquires California-based Ardent Hospice and Palliative Care

Aug 16

Pennant Non-GAAP EPS of $0.14 in-line, revenue of $116.3M beats by $4.02M

Aug 08

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

Jun 28

Is The Pennant Group, Inc. (NASDAQ:PNTG) Trading At A 48% Discount?

May 18

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Apr 29

Is Pennant Group (NASDAQ:PNTG) Using Too Much Debt?

Feb 11

An Intrinsic Calculation For The Pennant Group, Inc. (NASDAQ:PNTG) Suggests It's 50% Undervalued

Jan 21

Pennant Group (NASDAQ:PNTG) Will Want To Turn Around Its Return Trends

Jan 04

Is Pennant Group (NASDAQ:PNTG) Using Too Much Debt?

Oct 10

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di PNTG siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di PNTG siano aumentati.

Rendimento dei dividendi rispetto al mercato

Pennant Group Rendimento dei dividendi rispetto al mercato

Come si colloca il rendimento da dividendo di PNTG rispetto al mercato?
Segmento	Rendimento dei dividendi
Azienda (PNTG)	n/a
Fondo del 25% del mercato (US)	1.5%
Top 25% del mercato (US)	4.4%
Media del settore (Healthcare)	1.6%
Previsione dell'analista in 3 anni (PNTG)	n/a

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di PNTG rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di PNTG rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Distribuzione degli utili agli azionisti

Copertura degli utili: Dati insufficienti per calcolare il payout ratio di PNTG per determinare se i suoi pagamenti di dividendi sono coperti dagli utili.

Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché PNTG non ha segnalato alcun pagamento.

Pennant Group Dividendo

Dividendo criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sui dividendi

Recent updates

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

CEO & Director notifies of intention to sell stock

The Pennant Group, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Price target increased by 7.8% to US$27.50

Independent Director exercised options to buy US$1.3m worth of stock.

The Pennant Group, Inc. acquired Nurses On Wheels, Inc.

Now 21% undervalued

Here's Why Pennant Group (NASDAQ:PNTG) Can Manage Its Debt Responsibly

Price target increased by 13% to US$24.75

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. (NasdaqGS : PNTG) acquired South Davis Community Hospital, Inc.

The Pennant Group, Inc. to Report Q1, 2024 Results on May 06, 2024

New minor risk - Shareholder dilution

The Pennant Group, Inc., Annual General Meeting, May 23, 2024

President & COO exercised options to buy US$214k worth of stock.

The Pennant Group, Inc. (NASDAQ:PNTG) Not Flying Under The Radar

Price target increased by 22% to US$19.50

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. Provides Revenue Guidance for 2024

The Pennant Group, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

Price target increased by 10% to US$16.00

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

the Pennant Group, Inc. Provides Earnings Guidance for the Year 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Guardian Hospice of Texas and Guardian Hospice of Oklahoma.

The Pennant Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Valor HospiceCare.

Price target decreased by 7.1% to US$14.25

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q2, 2023 Results on Aug 08, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Bluebird Home Health, Bluebird Hospice, and Bluebird Home Care.

Price target decreased by 8.5% to US$15.33

The Pennant Group, Inc. Announces Jennifer Freeman Assume the Role of Senior Vice President of Strategic Partnerships

Investor sentiment deteriorates as stock falls 18%

The Pennant Group, Inc. acquired Assets Of Benefit Health Care.

The Returns On Capital At Pennant Group (NASDAQ:PNTG) Don't Inspire Confidence

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improves as stock rises 16%

Independent Chairman recently bought US$67k worth of stock

Investor sentiment improves as stock rises 20%

Is Pennant Group (NASDAQ:PNTG) A Risky Investment?

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Consensus forecasts updated

The Pennant Group, Inc. (NasdaqGS:PNTG) announces an Equity Buyback for $1 million worth of its shares.

Independent Director recently bought US$203k worth of stock

Consensus forecasts updated

Consensus forecasts updated

The Pennant Group, Inc. Announces Resignation of Derek Bunker,Chief Investment Officer, Executive Vice President and Corporate Secretary, Effective December 31, 2022

Price target decreased to US$15.40

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. Provides Earnings Guidance for the Year 2022

The Pennant Group, Inc. to Report Q3, 2022 Results on Nov 07, 2022

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Assets of Kenosha Visiting Nurse Association, Inc.

Price target decreased to US$18.00

Pennant Group (NASDAQ:PNTG) Is Reinvesting At Lower Rates Of Return

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Assets of Ardent Hospice and Palliative Care.

Pennant acquires California-based Ardent Hospice and Palliative Care

Price target increased to US$18.75

The Pennant Group, Inc. Reaffirms Revenue Guidance for the Full Year 2022

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Pennant Non-GAAP EPS of $0.14 in-line, revenue of $116.3M beats by $4.02M

The Pennant Group, Inc. to Report Q2, 2022 Results on Aug 08, 2022

The Pennant Group, Inc. Announces Resignation of Mr. Daniel Walker as Chief Executive Officer, Effective on August 1, 2022

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

The Pennant Group, Inc. to Appoint John Gochnour as President and Chief Operating Officer

Is The Pennant Group, Inc. (NASDAQ:PNTG) Trading At A 48% Discount?

Consensus forecasts updated

Price target decreased to US$20.50

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. Provides Revenue Guidance for the Full Year 2022

The Pennant Group, Inc. to Report Q1, 2022 Results on May 09, 2022